Table 2.
The comparison of oncologic outcomes between LDR brachytherapy and IMRT
Number of patients | Procedure | Definition | Median follow-up | Outcomes | |
---|---|---|---|---|---|
Zelefsky et al9 (2011) | 729 | LDR (144 Gy) (n = 448) vs. IMRT (81 Gy) (n = 281) | Phoenix | 77 mo | Low 7-yr bPFS LDR: 95% IMRT: 89% P = 0.004 |
Spratt et al10 (2014) | 870 | LDR + EBRT (n = 400) vs. IMRT (86.4 Gy) (n = 470) | Phoenix | 5.3 yr | Int. 7-yr bPFS LDR: 92% IMRT: 81% P = 0.004 |
Morris et al11 (ASCENDE-RT) (2017) | 398 | DE-EBRT (78 Gy) (n = 195) vs. LDR + EBRT (n = 188) | Phoenix | 78 mo | Int. ∼ High 7-yr bPFS LDR vs. DE-EBRT 86% vs. 75% P < 0.001 |
bPFS, biochemical progression-free survival; DE, dose escalated; EBRT, external beam radiation therapy; High, high-risk; IMRT, intensity modulated radiation therapy; Int., intermediate-risk; LDR, low-dose-rate brachytherapy; Low, low-risk.